CClinicalTrials.gg
CompletedNCT03839186Updated Mar 2, 2022

Pharmacogenetics Study on the Effects of Anesthetic Drugs on Circulatory Function

An observational study in Drug Reaction, Anesthetic and Hemodynamic Rebound, sponsored by Xiangya Hospital of Central South University. Completed at 1 site in China. Open to participants aged 20 Years to 75 Years. Per ClinicalTrials.gov, last updated 2022-03-02.

Sponsored by Xiangya Hospital of Central South University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
223
Ages
20 Years to 75 Years
Sex
All
01

Study summary

This study intends to study the effects of anesthetics on Circulatory Function Genomics and find the anesthetic effects in pharmacodynamics, pharmacokinetics, drug receptor or target DNA level differences, further guiding individual treatment in clinic, promoting the development of precision the medicine.The anesthesia medication during perioperative period is more and more accurate,reasonable and safe, so as to improve the satisfaction of the patients and their families in the perioperative period, to ensure the safety of patients.

Read the detailed description

This study is a non traumatic and non intervention study, and will use a large sample of clinical research, the number of subjects to be enrolled in the study group are 200 cases. The basic information of the study was included in the study before the operation. During the operation, the investigators need a collection of participants's arterial blood and monitor the hemodynamic index and anesthesia depth by bispectral index(BIS) . Further more,the investigators will follow up the participants' condition after operation.Dividing the patients into different groups according to their clinical features.The relationship between vital signs and the depth of anesthesia was analyzed and compared between different groups.Blood samples collected during the operation were detected by gene test. Comparing the results of genetic testing and clinical data analysis, then the investigators will find the differences in the expression of the gene polymorphisms of anesthetic drugs in the circulating function.

02

Conditions studied

  • Drug Reaction
  • Anesthetic
  • Hemodynamic Rebound
  • Gene

Keywords

  • personalized medicine
  • genetic polymorphism
  • pharmacogenetics
  • hemodynamic change
03

In context

Drug-Related Side Effects and Adverse Reactions

437 studies on the registry are indexed under Drug-Related Side Effects and Adverse Reactions; 76 are open to participants now.

This study's enrollment of 223 is below the median of 330 across 159 observational studies indexed under Drug-Related Side Effects and Adverse Reactions.

Browse Drug-Related Side Effects and Adverse Reactions studies →

Lead sponsor

Xiangya Hospital of Central South University is the lead sponsor of 170 studies on the registry; 76 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients from department of thoracic and cardiovascular surgery in Xiangya Hospital, Central South University

Inclusion criteria

  • Undergoing general anesthesia
  • Undergoing Cardiovascular surgery

Exclusion criteria

Exclusion Criteria:

  • ASA granding more than five
  • Severe organ dysfunction
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
223 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Genotyping results of anesthetic drugs

    Genotype information of SNP related to anesthetic drug metabolism, such as AA, AG or GG

    Time frame: one year

Secondary outcomes

  1. vital signs

    The percentage of change in mean arterial pressure and heart rate

    Time frame: one year

Other outcomes

  1. depth of anesthesia

    The value of BIS

    Time frame: one year

  2. prognostic indicator

    The days of patients' hospital stay time

    Time frame: one year

07

Study locations

1 site
  • Xiangya Hospital of Central South University
    Changsha, Hunan 410000, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03839186
Lead sponsor
Xiangya Hospital of Central South University
Responsible party
Sponsor
First posted
Feb 15, 2019
Start date
Aug 2016
Primary completion
Dec 2018
Completion
Apr 2019
Last update
Mar 2, 2022

Study contacts

e wang, doctor
study chair · Xiangya Hospital of Central South University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion